GLUE
Monte Rosa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.13
−3.73%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.12x
- Price / sales
- 36.02x
- Price / cash flow
- -16.84x
Enterprise value
- Enterprise value
- $451.7M
- EV / sales
- 15.73x
- EV / EBITDA
- -2.90x
- EV / EBIT
- -2.48x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026